Proof-of-concept phase IIa trial investigating the efficacy and tolerability of DRM 04B in patients with primary axillary hyperhidrosis
Latest Information Update: 19 Feb 2014
Price :
$35 *
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Adverse reactions; Therapeutic Use
- 19 Feb 2014 New trial record